SCHEMBL20059105

SCHEMBL20059105

CCOc1nc(N)nc2c1ncn2C[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C[C@@H]1C

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 4/20 0.40
▸ P2RX3 P56373 4/20 0.40
▸ P2RX4 Q99571 3/20 0.40
▸ ENPP1 P22413 2/20 0.40
▸ P2RY1 P47900 2/20 0.40
▸ P2RY6 Q15077 1/20 0.40
▸ P2RY11 Q96G91 1/20 0.40
▸ P2RY12 Q9H244 1/20 0.39
▸ P2RX2 Q9UBL9 1/20 0.39
▸ RNASEL Q05823 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ POLG P54098 1/20 0.38
▸ FUT5 Q11128 1/20 0.37
▸ ENTPD1 P49961 1/20 0.37
▸ PNP P00491 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20058653 0.90 P2RY1 (0.47) P2RX1P2RX3P2RX4ENPP1P2RY1
SCHEMBL16024938 0.85 P2RY1 (0.48) P2RX1P2RX3P2RX4ENPP1P2RY1
SCHEMBL23584307 0.83 MGMT (0.40) —
SCHEMBL20879494 0.82 P2RX3 (0.55) P2RX1P2RX3P2RX4P2RY1P2RX2
SCHEMBL22475057 0.77 POLG (0.54) P2RY6P2RY12POLBPOLG
SCHEMBL19827632 0.77 CA5A (0.44) P2RX3P2RY1P2RY11RNASEL
SCHEMBL16000595 0.76 P2RY1 (0.42) P2RX1P2RX3P2RX4ENPP1P2RY1
SCHEMBL31029199 0.76 P2RY1 (0.68) P2RX1P2RX3P2RX4ENPP1P2RY1
SCHEMBL24081936 0.76 NT5E (0.40) P2RX1P2RX3P2RX4ENPP1P2RY1
SCHEMBL19187036 0.75 NT5E (0.41) P2RX1P2RX3P2RX4ENPP1P2RY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906579-B1 2'-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION IDENIX PHARMACEUTICALS LLC (US) 2018-04-18 — — EP disclosed
Send feedback